Home › Funds › Zurich Insurance Group Ltd/FI › ABT
Zurich Insurance Group Ltd/FI position in ABT
ABBOTT LABORATORIES · Health Care
Zurich Insurance Group Ltd/FI reported holding 677,392 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$66.9M, representing 0.47% of its reported portfolio and ranking #44 among its reported holdings. Zurich Insurance Group Ltd/FI has disclosed ABT holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Zurich Insurance Group Ltd/FI's ABT position evolved
Zurich Insurance Group Ltd/FI first disclosed a stake in ABT in Q1 2024 at 19,000 shares (US$2.2M). The position peaked in Q1 2025 at 1,115,514 shares, worth US$148.0M. Across 11 filings, Zurich Insurance Group Ltd/FI increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 677,392 shares valued at US$66.9M — an increase of 376,682 shares quarter over quarter.. Notable position changes include a 5771% increase in Q1 2025 (shares rose 3% over the following quarter), a 1483% increase in Q2 2026 (shares rose 10% over the following quarter), a 125% increase in Q3 2026 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 19.00K | $2.16M | New |
| Q2 2024 | 19.00K | $1.97M | Hold |
| Q3 2024 | 19.00K | $2.17M | Hold |
| Q4 2024 | 19.00K | $2.15M | Hold |
| Q1 2025 | 1.12M | $147.97M | Add |
| Q2 2025 | 864.71K | $117.61M | Reduce |
| Q3 2025 | 19.00K | $2.54M | Reduce |
| Q4 2025 | 19.00K | $2.38M | Hold |
| Q1 2026 | 19.00K | $1.95M | Hold |
| Q2 2026 | 300.71K | $27.29M | Add |
| Q3 2026 | 677.39K | $66.95M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.65B), Charles Schwab Investment Management (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 57.16M sh · $5.65B · Q3 2026
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- Capital Research Global Investors 44.98M sh · $4.45B · Q3 2026
- Capital International Investors 35.46M sh · $3.51B · Q3 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Franklin Resources 20.44M sh · $2.36B · Q3 2026
- Deutsche Bank AG 17.69M sh · $1.75B · Q3 2026
- MFS Investment Management 14.93M sh · $1.48B · Q3 2026
More on Zurich Insurance Group Ltd/FI
FAQ
How long has Zurich Insurance Group Ltd/FI held ABT?
Zurich Insurance Group Ltd/FI has disclosed ABT holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Zurich Insurance Group Ltd/FI's current position in ABT?
As of Q3 2026, Zurich Insurance Group Ltd/FI holds 677.39K shares of ABT (ABBOTT LABORATORIES), valued at $66.95M, representing 0.47% of its reported portfolio and ranking #44.
Has Zurich Insurance Group Ltd/FI been buying or selling ABT?
In the latest 13F filing (Q3 2026), Zurich Insurance Group Ltd/FI increased its position in ABT. The position peaked in Q1 2025 at 1.12M shares.
Which other funds hold ABT?
Other major institutional holders of ABT include Vanguard Group, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Charles Schwab Investment Management, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.